Barinthus Biotherapeutics plc American (BRNS) Revenue by Year
Barinthus Biotherapeutics plc American generated $0 in revenue in fiscal year 2025. This represents a decrease of 100.0% from the prior fiscal year. The table below carries 6 fiscal years, from 2020 to 2025, and the quarters Barinthus Biotherapeutics plc American has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
BRNS Revenue by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
BRNS Revenue by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
What revenue means
Revenue is everything the company billed its customers over the period, counted before any cost of running the business comes out of it.
More Barinthus Biotherapeutics plc American financials
Frequently Asked Questions
What was Barinthus Biotherapeutics plc American's revenue in fiscal year 2025?
Barinthus Biotherapeutics plc American generated $0 in revenue in fiscal year 2025.
How fast is Barinthus Biotherapeutics plc American's revenue growing?
Barinthus Biotherapeutics plc American (BRNS) revenue fell by 100.0% year over year, from $15.0M to $0 in fiscal year 2025.
How has Barinthus Biotherapeutics plc American's revenue changed over the years?
Across the 6 fiscal years this page covers, Barinthus Biotherapeutics plc American (BRNS) revenue went from $4.8M in fiscal year 2020 to $0 in fiscal year 2025.
What does revenue mean on a financial statement?
Revenue is everything the company billed its customers over the period, counted before any cost of running the business comes out of it. This page lists what Barinthus Biotherapeutics plc American (BRNS) reported on that line in every period on record.